DUNE

Edgewise Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights

Retrieved on: 
Giovedì, Maggio 9, 2024
Health, Communications, General Health, Clinical Trials, Pharmaceutical, Biotechnology, Public Relations, Investor Relations, TNNI2, Safety, Pharmacokinetics, DUNE, Duchenne, McArdle, Ageing, Exercise, Creatine kinase, Patient, MRI, CK, Duchenne muscular dystrophy, Myopathy, Biomarker, Therapy, ARCH, Muscular dystrophy

Edgewise Therapeutics, Inc., (Nasdaq: EWTX), a leading muscle disease biopharmaceutical company, today reported financial results for the first quarter of 2024 and recent business highlights.

Key Points: 
  • Edgewise Therapeutics, Inc., (Nasdaq: EWTX), a leading muscle disease biopharmaceutical company, today reported financial results for the first quarter of 2024 and recent business highlights.
  • The Company expects to report CANYON data in the fourth quarter of 2024.
  • Research and development (R&D) expenses were $27.7 million for both the first quarter of 2024 and for the immediately preceding quarter.
  • General and Administrative (G&A) expenses were $7.1 million for the first quarter of 2024, compared to $6.2 million for the immediately preceding quarter.

Edgewise Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights

Retrieved on: 
Giovedì, Febbraio 22, 2024
Health, Other Health, Clinical Trials, Pharmaceutical, Cardiology, Biotechnology, Muscular dystrophy, Research, American Heart Association, Education, R9, MESA, Ageing, Fast Track, NSAA, McArdle, DUNE, Myopathy, Therapy, WMS, LYNX, ODD, Safety, Biomarker, Pharmacokinetics, HCM, Clinical trial, Caregiver, FOX, FDA, Muscle contraction, Engagement, Duchenne muscular dystrophy, ARCH, Administration, Patient, Disease, Pharmaceutical industry

Edgewise Therapeutics, Inc., (Nasdaq: EWTX), a leading muscle disease biopharmaceutical company, today reported financial results for the fourth quarter and full year of 2023 and recent business highlights.

Key Points: 
  • Edgewise Therapeutics, Inc., (Nasdaq: EWTX), a leading muscle disease biopharmaceutical company, today reported financial results for the fourth quarter and full year of 2023 and recent business highlights.
  • “In 2023, we made tremendous progress advancing our novel muscle-targeted therapeutics in the clinic,” said Kevin Koch, Ph.D., President and Chief Executive Officer of Edgewise.
  • Research and development (R&D) expenses were $27.7 million for the fourth quarter of 2023, compared to $23.8 million for the immediately preceding quarter.
  • General and Administrative (G&A) expenses were $6.2 million for the fourth quarter of 2023, compared to $5.7 million for the immediately preceding quarter.

Excavation of colossal caverns for Fermilab’s DUNE experiment completed

Retrieved on: 
Giovedì, Febbraio 1, 2024
CERN, Physics, Deep Underground Neutrino Experiment, Travel, Research, Cave, DOE, Accident, Behavior, DUNE, Mining, Animation, Energy, Uranium mining

Located a mile below the surface, the three colossal caverns are at the core of a new research facility that spans an underground area about the size of eight soccer fields.

Key Points: 
  • Located a mile below the surface, the three colossal caverns are at the core of a new research facility that spans an underground area about the size of eight soccer fields.
  • The caverns provide space for four large neutrino detectors—each one about the size of a seven-story building (see 2-minute animation ).
  • With DUNE, scientists will look for neutrinos and examine the behavior of a neutrino beam produced at Fermilab, located near Chicago, about 800 miles east of the caverns.
  • “The completion of the excavation of these enormous caverns is a significant achievement for this project,” said U.S. Project Director Chris Mossey.

Global Hydrogen Energy Completes Business Combination with Dune Acquisition Corporation to Form Publicly Traded Global Gas Corporation

Retrieved on: 
Giovedì, Dicembre 21, 2023
Hydrogen, Failure, Business analyst, Probability, Business, DUNE, Acquisition, LLP, Alston & Bird, Gas, Hearing, Winston & Strawn, Risk, Sidley Austin, COVID-19, Growth, Carbon, Security (finance), Information technology, Natural gas, Cryptocurrency

Global Gas is a Founder-Led, Minority-Owned Business

Key Points: 
  • Global Gas is a Founder-Led, Minority-Owned Business
    WEST PALM BEACH, Fla.& NEW YORK, Dec. 21, 2023 (GLOBE NEWSWIRE) -- Global Hydrogen Energy LLC (“Global Hydrogen”), which seeks to be a leader in the sustainable energy transition as a next-generation industrial gas supplier, and Dune Acquisition Corporation (Nasdaq: DUNEU, DUNE, DUNEW) (“Dune”), a special purpose acquisition company, today announced the completion of its previously announced business combination.
  • Headquartered in New York, Global Gas is led by Founder and Chief Executive Officer William B. Nance, who has over a decade of hydrogen and industrial gas experience.
  • In conjunction with the select specifications of its clients and development partners, Global Gas can deliver both Electrolyzer and Steam Methane Reforming offerings.
  • “The completion of our business combination with Dune positions Global Gas to be a leader in the rapidly growing hydrogen and carbon recovery ecosystem.

International science organizations sign agreement to provide hardware for the Deep Underground Neutrino Experiment

Retrieved on: 
Mercoledì, Dicembre 6, 2023
Proton, State University of Campinas, Partnership, CERN, Soil, Particle physics, DUNE, Acquisition, Research, Physics, Electronics, University, Behavior, DOE, IN2P3, SURF, INFN, Student, Engineering, University of Bern, Calibration, Deep Underground Neutrino Experiment, Renewable energy

Batavia, Illinois, Dec. 06, 2023 (GLOBE NEWSWIRE) -- The Deep Underground Neutrino Experiment — also known as DUNE — is an international mega science experiment that will use enormous particle detectors to study the behavior of neutrinos, which might indicate why we live in a matter-dominated universe.

Key Points: 
  • Batavia, Illinois, Dec. 06, 2023 (GLOBE NEWSWIRE) -- The Deep Underground Neutrino Experiment — also known as DUNE — is an international mega science experiment that will use enormous particle detectors to study the behavior of neutrinos, which might indicate why we live in a matter-dominated universe.
  • “DUNE will help answer some of the biggest questions in the universe and has the potential to transform the field of neutrino physics.
  • Notably, CERN’s commitment to LBNF and DUNE represents its first investment in infrastructure for a physics experiment outside of Europe.
  • To pursue these science goals, DUNE will study neutrino oscillation, a phenomenon in which a neutrino’s property, called flavor, changes as it travels.

Edgewise Therapeutics Reports Third Quarter 2023 Financial Results and Recent Business Highlights

Retrieved on: 
Giovedì, Novembre 9, 2023
Biotechnology, Health, Pharmaceutical, Physical Therapy, Cardiology, LYNX, Research, FOX, DUNE, Ageing, Education, Biomarker, Muscular dystrophy, Muscular Dystrophy Association, NSAA, G&A, Myopathy, Glycogen storage disease type V, American Heart Association, WMS, R, Muscle contraction, Pharmacokinetics, Dystrophinopathy, Disorder, Glycogen, PK, Clinical trial, Duchenne muscular dystrophy, McArdle, Safety, HCM, Therapy, Patient, MESA, R9, Administration, Pharmaceutical industry, Edgewise, Duchenne, Becker

Edgewise Therapeutics, Inc. (Nasdaq: EWTX), a leading muscle disease biopharmaceutical company, today reported financial results for the third quarter of 2023 and recent business highlights.

Key Points: 
  • Edgewise Therapeutics, Inc. (Nasdaq: EWTX), a leading muscle disease biopharmaceutical company, today reported financial results for the third quarter of 2023 and recent business highlights.
  • “I’m thrilled with the progress we’ve made in 2023 across our skeletal and cardiovascular programs,” said Kevin Koch, Ph.D., President and Chief Executive Officer of Edgewise.
  • Research and development (R&D) expenses were $23.8 million for the third quarter of 2023, compared to $19.6 million for the immediately preceding quarter.
  • General and Administrative (G&A) expenses were $5.7 million for the third quarter of 2023, compared to $5.8 million for the immediately preceding quarter.

Edgewise Therapeutics Reports Second Quarter 2023 Financial Results and Recent Business Highlights

Retrieved on: 
Giovedì, Agosto 10, 2023
Research, FDA, Genetics, Clinical Trials, Cardiology, Biotechnology, Health, Pharmaceutical, Science, Becker, Creatine kinase, Myopathy, LYNX, Pharmacokinetics, DUNE, Biomarker, ARCH, Disorder, Therapy, HCM, Safety, Pharmaceutical industry

Edgewise Therapeutics, Inc., (Nasdaq: EWTX), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of innovative treatments for severe, genetic neuromuscular and cardiac disorders for which there is significant unmet medical need, today reported financial results for the second quarter of 2023 and recent business highlights.

Key Points: 
  • Edgewise Therapeutics, Inc., (Nasdaq: EWTX), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of innovative treatments for severe, genetic neuromuscular and cardiac disorders for which there is significant unmet medical need, today reported financial results for the second quarter of 2023 and recent business highlights.
  • Research and development (R&D) expenses were $19.6 million for the second quarter of 2023, compared to $19.9 million for the immediately preceding quarter.
  • General and Administrative (G&A) expenses were $5.8 million for the second quarter of 2023, compared to $5.8 million for the immediately preceding quarter.
  • Net loss and net loss per share for the second quarter of 2023 was $21.5 million or $0.34 per share, compared to $22.9 million or $0.36 per share for the immediately preceding quarter.

Global Hydrogen Energy Selected by Port of Brownsville as Private Development Partner in $15 Million Federal Funding Application

Retrieved on: 
Giovedì, Luglio 20, 2023
Hydrogen, BND, PALM, CFI, U.S. Department of Agriculture Cotton Annex, Infrastructure Investment and Jobs Act, DUNE, FL, DOT, Acquisition, Collection, Port of Brownsville, CO2, Transport

Global Hydrogen Energy LLC (“Global Hydrogen”) was selected as the Port’s private hydrogen project development partner.

Key Points: 
  • Global Hydrogen Energy LLC (“Global Hydrogen”) was selected as the Port’s private hydrogen project development partner.
  • Grant award decisions are expected later this summer.
  • In 2021, the BND processed approximately 8.9 million short tons of domestic and foreign cargo.
  • “Global Hydrogen is pleased to have been selected as the Brownsville Navigation District’s private hydrogen development partner and we look forward to continuing to work with the Port’s Commissioners and executive leadership.

Carter Glatt to be Chairman Nominee of Global Hydrogen Energy LLC's Post-Closing Board

Retrieved on: 
Venerdì, Maggio 19, 2023
Hydrogen, SPAC, PALM, VMware, Software as a service, Senior, Dune, GTY, DUNE, Dartmouth College, Accenture, Public sector, Acquisition, Dell EMC, Growth, Transport, Corporate development, Cryptocurrency, Management

WEST PALM BEACH, Fla. & NEW YORK, May 19, 2023 (GLOBE NEWSWIRE) -- Global Hydrogen Energy LLC (“Global Hydrogen”), which seeks to be a leader in the sustainable energy transition as a next-generation industrial gas supplier, today announced that Carter Glatt, CEO and Director of Dune Acquisition Corporation (Nasdaq: DUNEU, DUNE, DUNEW) (“Dune”), will serve as Chairman Nominee of its post-closing Board.

Key Points: 
  • WEST PALM BEACH, Fla. & NEW YORK, May 19, 2023 (GLOBE NEWSWIRE) -- Global Hydrogen Energy LLC (“Global Hydrogen”), which seeks to be a leader in the sustainable energy transition as a next-generation industrial gas supplier, today announced that Carter Glatt, CEO and Director of Dune Acquisition Corporation (Nasdaq: DUNEU, DUNE, DUNEW) (“Dune”), will serve as Chairman Nominee of its post-closing Board.
  • On May 15, 2023, Dune, a special purpose acquisition company, and Global Hydrogen announced that they have entered into a definitive agreement for a business combination, which would result in Global Hydrogen becoming a publicly listed company.
  • Coupled with his background in energy and energy transition, Carter’s history of scaling assets as a public company operating executive will deeply serve us as a resource at Global Hydrogen,” said William B. Nance, Founder and Chief Executive Officer of Global Hydrogen.
  • By continuing to partner with William and his team at the Board level, I look forward to Global Hydrogen establishing itself as a pre-eminent resource for all customers supporting the clean economy,” said Mr. Glatt.

Global Hydrogen Energy LLC to Become a Publicly Traded Company Through a Business Combination With Dune Acquisition Corporation

Retrieved on: 
Lunedì, Maggio 15, 2023
Hydrogen, Heart, Private sector, Partnership, Winston & Strawn, Combination company, Oxygen, DUNE, Sidley Austin, Carbon, Dune (board game), Securities and Exchange Commission (Nigeria), Acquisition, Natural gas, Transport, Cryptocurrency

All Existing Global Hydrogen Shareholders to Roll 100% of their Equity into the Combined Company, which is Expected to be Listed on Nasdaq

Key Points: 
  • All Existing Global Hydrogen Shareholders to Roll 100% of their Equity into the Combined Company, which is Expected to be Listed on Nasdaq
    WEST PALM BEACH, Fla. & NEW YORK, May 15, 2023 (GLOBE NEWSWIRE) --  Global Hydrogen Energy LLC (“Global Hydrogen”), which seeks to be a leader in the sustainable energy transition as a next-generation industrial gas supplier, and Dune Acquisition Corporation (Nasdaq: DUNEU, DUNE, DUNEW) (“Dune”), a special purpose acquisition company, today announced that they have entered into a definitive agreement for a business combination, which would result in Global Hydrogen becoming a publicly listed company.
  • Headquartered in New York, Global Hydrogen is led by Founder and Chief Executive Officer William B. Nance, who has over a decade of hydrogen and industrial gas experience.
  • Global Hydrogen is a 100% minority-owned business that targets both private and publicly-funded hydrogen development and carbon recovery projects, including projects supported by local, county, state, and national- level governments.
  • Global Hydrogen sees a large addressable market for hydrogen and carbon recovery infrastructure and rapidly growing demand for low carbon hydrogen and recovered carbon dioxide and oxygen.